Market
Scenario:
Optical coherence tomography (OCT) is non-invasive imaging technology.
The device generates a false-color representation of the tissue structure, on
the micron scale in situ and in real time.
The OCT is analogous to ultrasound imaging, except that it uses light
instead of sound. Early OCT systems were based on time-domain (TD) optical
technology, but in recent years, Spectral-domain OCT (SD-OCT) succeeded TD-OCT
and addressed some of its limitations. The SD-OCT is 50-1000 times faster than
the TD technique. The swept-source OCT (SS-OCT) has also attracted a great deal
of attention in OCT market, as SS-OCT provides >200,000 A-scans/second with
~5-7 µm axial resolution.
Intended Audience:
·
Medical Devices Companies
·
Hospitals & Clinics
·
Diagnostic Centers
·
Research and Development (R&D) Companies
·
Government Research Institute
·
Academic Institutes and Universities
Segmentation:
The global optical coherence tomography market is segmented
on the basis of technology, application, and type of devices.
On the basis of the technology, the market is classified into
spectral-domain OCT (SD-OCT), swept-source OCT, and others.
On the basis of the type of devices, the market is segmented
into handheld OCT devices, tabletop OCT devices, catheter-based OCT devices,
and others.
Key Findings:
The global optical coherence tomography market is expected to
reach USD 1483.49 million by 2023 at a CAGR of 8.9%.
On the basis of the Application, ophthalmology segment is
expected to command the largest market share of 53.6% over the review period,
and Dermatology is expected to grow at the fastest CAGR of 9.3% during the
forecast period 2017-2023
Asia Pacific is the fastest growing market, which is expected
to grow at a CAGR of 9.4% over the 2017-2023
Regional
Analysis
The Americas dominate the optical coherence tomography market
owing to the increasing prevalence of prevalence of diabetic retinopathy, and
other eye diseases, and the presence of the leading players in the region.
According to the 2017 data suggested by Genentech, Inc., around 200,000 new
cases of wet AMD are diagnosed in the United States each year. It is also
reported that Diabetic retinopathy also impacts around 7.7 million Americans,
and the number is expected to escalate to 11.3 million by 2030. Due to
increasing acceptance of OCT systems multitude of products have been introduced
by leading players, such as ARGOS by Santec, SPECTRALIS by Heidelberg, and
others. In November 2016, Carl Zeiss received FDA approval for PLEX Elite
9000, and commercially available in the United States.
Key Players:
Some of key the players in the optical coherence tomography
market are Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo Corporation,
KONINKLIJKE PHILIPS N.V, B. Braun Melsungen AG, Boston Scientific Corporation,
Topcon Corporation, NIDEK Co., Ltd, Novacam Technologies Inc, OPTOPOL
Technology S.A, Heidelberg Engineering GmbH, Optovue, Michelson Diagnostics,
Thorlabs Inc., Agfa Healthcare, Imalux Corporation, and others.
Get Your
Customized Report @https://www.marketresearchfuture.com/reports/optical-coherence-tomography-market-1328
Table Of
Contents:
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 Assumptions & Limitations 17
2.1.1 Assumptions 17
2.1.2 Limitations 17
3 RESEARCH METHODOLOGY
3.1 Primary Research Methodology 21
3.2 Secondary Research Methodology 22
3.3 Market Share Analysis 22
3.4 Trade Analysis 22
3.5 Market Pricing Approach 23
4 MARKET DYNAMICS
4.1 Introduction 25
4.2 Drivers 26
4.2.1 Increasing Prevalence Of Diabetic Retinopathy And Other
Eye Diseases 26
4.2.2 Increasing Technological Advancements 27
TOC
Continued…!
Get
Discount @https://www.marketresearchfuture.com/check-discount/1328
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment